News
Vifor Pharma delivers strong full year results 2020 with an EBITDA of 576 million Swiss Francs representing over 29% growth1
Regulatory News:
Vifor Pharma Group reported stable net sales and a continued strong increase in profitability in 2020, despite challenges to patient access from COVID-19 and the impact of a much
Vifor Pharma schliesst 2020 mit starkem Geschäftsergebnis und EBITDA-Anstieg um über 29% auf 576 Millionen Schweizer Franken ab1
Regulatory News:
Die Vifor Pharma Gruppe weist auch für 2020 trotz des durch COVID-19 erschwerten Patientenzugangs und den Folgen des gegenüber dem US-Dollar deutlich stärkeren Schweizer Franken
UBS Advisor David Schachter Named to Forbes/SHOOK Best-in-State Wealth Advisors List
UBS Wealth Management USA announced today that David Schachter, a Financial Advisor in the firm’s West Los Angeles Market, has been named to the Forbes/SHOOK Research Best-in-State Wealth Advisors
ABB Publishes 2020 Annual Report
The 2020 annual report is now available electronically at www.abb.com/groupreports. It provides comprehensive information on the company and its strategy, business, governance and financial
Notice of ABB’s Annual General Meeting on March 25, 2021
ABB today published the invitation to its Annual General Meeting (AGM), which will be held on Thursday, March 25, 2021. The invitation can be found above and on ABB’s investor relations website at
RecovR Disrupts the Vehicle Lot Management and Theft Recovery Market with Innovative New Capabilities & Business Model
Kudelski IoT – a unit of the Kudelski Group (SIX:KUD), a leading global technology and security provider – today announced the launch of RecovR, a two-in-one lot management and theft recovery
ABB: Q4 and Full-Year 2020 Results
ABB (SWX:ABBN): Solid end to challenging year
FOURTH QUARTER 2020 HIGHLIGHTS
-
Orders $7.0 billion, +2%; comparable -1%1
-
Revenues $7.2 billion, +2%; comparable 0%
-
Income from operations $578
Vifor Pharma to propose Dr Alexandre LeBeaut as Board member
Regulatory News:
Vifor Pharma today announced that the Board of Directors will propose Dr Alexandre LeBeaut for election to the Board at the next Annual General Meeting on 6 May 2021.
Jacques
VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201221005694/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
ABB appoints Carolina Granat as Chief Human Resources Officer
ABB announced today that Carolina Granat is to succeed Sylvia Hill as Chief Human Resources Officer and member of the Executive Committee, effective January 1, 2021.
Granat currently serves as
Vifor Pharma supports Iron Deficiency Day 2020 to highlight global impact on health and gender inequality
Regulatory News:
Vifor Pharma is marking the sixth anniversary of Iron Deficiency Day, focused on raising international awareness of the serious health impact of iron deficiency and iron
VFMCRP and Fresenius Kabi expand collaboration in nephrology in China with Veltassa® agreement
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201118005914/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
ABB Capital Markets Day 2020
ABB will be hosting its Capital Markets Day today, November 19, starting 11.30 am CET, at which CEO, Björn Rosengren, and CFO, Timo Ihamuotila, as well as the four business area Presidents, will
Ares Management Becomes Largest Single Shareholder in Peach Property Group AG
Ares Management Corporation (“Ares”) (NYSE: ARES), a leading global alternative investment manager, announced today that a fund managed by its Real Estate Group has converted a CHF 155 million
Full Results From AFFIRM-AHF Study Show Ferinject® Significantly Reduces Hospitalizations After Acute Heart Failure in Patients With Iron Deficiency
Regulatory News:
Vifor Pharma today presented the full results from the AFFIRM-AHF study at the 2020 American Heart Association (AHA) Scientific Sessions virtual congress. Simultaneously, results
Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201108005065/en/
Vifor Pharma and Angion Biomedica Corp. (Angion)
Kudelski IoT Enables Secure “Phone as Key” Solution for Management of Shared Vehicle Access
The Kudelski Group (SIX: KUD.S), the world leader in digital security and IoT solutions, today announced the availability of its solution for secure, effortless access to vehicles using an
VFMCRP and ChemoCentryx announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201102005955/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
BB Biotech: Ein drittes Quartal zum Abhaken
BB Biotech (WKN: A0NFN3) legte heute seinen Quartalsbericht vor und informierte zugleich über „erhöhte Übernahmeaktivitäten“ im Pharmasektor, aus denen die Investmentgesellschaft selbst Kapital
ABB: Q3 2020 Results
“Third quarter revenues in all business areas were still dampened due to the impact of COVID-19, although a strong recovery in China and ongoing cost mitigation efforts supported a strong
Vifor Pharma and Cara Therapeutics sign US license agreement for i.v. Korsuva™* to treat dialysis patients with pruritus
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005725/en/
Vifor Pharma and Cara Therapeutics, Inc
Santhera: Endgültiger Studienstopp von DMD-Medikament
Dämpfer für Santhera Pharmaceuticals (WKN: A0LCUK): Die Schweizer Biotechschmiede stellt die zulassungsrelevante Phase-3-Studie mit Puldysa bei Patienten mit Duchenne-Muskeldystrophie (DMD) ein. Die
ABB Enhances Portfolio of High-Speed Industrial Robots With Codian Acquisition
ABB has acquired Codian Robotics B.V., a leading provider of delta robots, which are used primarily for high-precision pick and place applications. Codian Robotics’ offering includes a hygienic
Vifor Pharma announces outcome of AFFIRM-AHF topline data
Regulatory News:
Vifor Pharma today announced topline data from its AFFIRM-AHF study evaluating the effect of Ferinject® (intravenous ferric carboxymaltose) on heart failure hospitalizations and
Vifor Pharma Group Announces Successful Sale of OM Pharma
Regulatory News:
Vifor Pharma has today announced the successful sale of 100% of the share capital of OM Pharma, a Vifor Pharma Group company to Optimus Holding Ltd. The terms of the deal